Markets.com Logo

ONCOZ

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    7.6946$
  • Previous Close
    7.1642$
  • 52 Week Change
    8.95$
  • Day Range
    0.53$
  • 52 Week High/Low
    3.15$ - 12.1$
  • Dividend Per Share
    --
  • Market cap
    99 274 K$
  • EPS
    0.0038
  • Beta
    1.443
  • Volume
    --

About

ONCOZ.ST is the ticker symbol for OncoZenge AB, a Swedish pharmaceutical company listed on the Nasdaq First North Growth Market in Stockholm. The company focuses on developing and commercializing innovative supportive care products to improve the quality of life for cancer patients. Their lead product candidate is Mucogard, a novel treatment for oral mucositis, a common and debilitating side effect of cancer therapy. OncoZenge aims to address the unmet needs of cancer patients undergoing treatment and improve their overall well-being.
NBIS stock price prediction: Will Nebius Group (NBIS) stock rally in 2026?

NBIS stock price prediction: Will Nebius Group (NBIS) stock rally in 2026?

Ghko B|--
Tesla Stock (NASDAQ:TSLA) jumps 4.3%: Why are Tesla shares trading up?

Tesla Stock (NASDAQ:TSLA) jumps 4.3%: Why are Tesla shares trading up?

Ghko B|--
AVGO stock crashed 5.6% today: what’s happening with Broadcom Inc?

AVGO stock crashed 5.6% today: what’s happening with Broadcom Inc?

Ghko B|--
AVGO stock dropped 11% today: Why is Broadcom Inc stock going down?

AVGO stock dropped 11% today: Why is Broadcom Inc stock going down?

Frances Wang|--
RGTI stock is dropping: Where will Rigetti Computing be in 5 years?

RGTI stock is dropping: Where will Rigetti Computing be in 5 years?

Frances Wang|--
Gold Price Forecast: XAU/USD above $4,300, will gold price continue to rise?

Gold Price Forecast: XAU/USD above $4,300, will gold price continue to rise?

Frances Wang|--
NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

Frances Wang|--

Factors

Company Performance: Revenue, profitability, and clinical trial results of OncoZymes AS directly influence investor confidence and stock price.

Market Sentiment: Overall market conditions, investor risk appetite, and industry trends affect ONCOZ.ST like other stocks.

Regulatory Approvals: Approval or rejection of drugs in OncoZymes' pipeline significantly impacts the company's future prospects and share value.

Competition: The presence of competing products or companies in the oncology space can affect market share and investor perception.

Economic Conditions: Macroeconomic factors like interest rates, inflation, and economic growth can impact investment decisions and stock valuations.

News & Events: Company-specific news, industry conferences, and global health events can all influence ONCOZ.ST stock price.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

Best CFD Trading Platform for 2026: How to Choose CFD Trading Brokers?

Best CFD Trading Platform for 2026: How to Choose CFD Trading Brokers?

Ghko B|--
What does CFD mean in trading: How to start CFD Trading in 2026?

What does CFD mean in trading: How to start CFD Trading in 2026?

Ghko B|--
A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

Ghko B|--